In vitro and in vivo studies proved chemokine IL-8 is overexpressed in CRC cells and has tumor-promoting and pro-angiogenic effects along with the increase in metastatic and chemoresistance property suggesting, IL-8 to be a potential target for colorectal cancer therapy [63]. The gene discussed is CXCL8; the disease is colorectal carcinoma.